Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Target ID: TTDR01337

Target Information
NameHistone Deacetylase 8    
Type of targetResearch target    
DiseaseNot Available
Target ValidationClick to Find Target Validation Information.    
QSAR ModelClick to Find Target QSAR Model.    
Inhibitor (E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one[1]
2- (methylsulfonylthio)ethyl 2-propylpentanoate[2]
4-Chloro-N- (5-hydroxycarbamoyl-pentyl)-benzamide[5]
4-Dimethylamino-N- (6-mercapto-hexyl)-benzamide[6]
4-Hydroxy-N- (5-hydroxycarbamoyl-pentyl)-benzamide[5]
4-Phenylbutyrohydroxamic acid[7]
5- (4-Chloro-phenyl)-pentanoic acid hydroxyamide[8]
5- (4-hydroxyphenyl)-3H-1,2-dithiole-3-thione[2]
5-Mercapto-pentanoic acid phenylamide[6]
6- (2-Bromo-acetylamino)-hexanoic acid phenylamide[6]
6- (2-mercaptoacetamido)-N-phenylhexanamide[9]
6-Mercapto-hexanoic acid phenylamide[6]
6-benzenesulfinylhexanoic acid hydroxamide[10]
6-benzenesulfonylhexanoic acid hydroxamide[10]
6-phenylsulfanylhexanoic acid hydroxamide[10]
7- (Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one[1]
7- (Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one[11]
7- (Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one[1]
7- (Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one[1]
7-Mercapto-heptanoic acid benzothiazol-2-ylamide[6]
7-Mercapto-heptanoic acid biphenyl-3-ylamide[6]
7-Mercapto-heptanoic acid biphenyl-4-ylamide[6]
7-Mercapto-heptanoic acid phenylamide[6]
7-Mercapto-heptanoic acid pyridin-3-ylamide[6]
7-Mercapto-heptanoic acid quinolin-3-ylamide[6]
8- (Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one[1]
8-Mercapto-octanoic acid phenylamide[6]
8-Oxo-8-phenyl-octanoic acid[5]
9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide[11]
9- (Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one[11]
Azithromycin-N-benzyltriazolylhexahydroxamic Acid[12]
Azithromycin-N-benzyltriazolylnonahydroxamic Acid[12]
Azithromycin-N-benzyltriazolyloctahydroxamic Acid[12]
Azithromycinarylalkylhydroxamic Acid[12]
Cyclostellettamine derivative[13]
Desclasinose Azithromycinarylalkyl Hydroxamate[12]
N- (2-Mercapto-ethyl)-N'-phenyl-oxalamide[14]
N- (2-Mercapto-ethyl)-N'-phenyl-succinamide[14]
N- (5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide[5]
N- (6-Hydroxycarbamoyl-hexyl)-benzamide[5]
N- (6-Mercapto-hexyl)-benzamide[6]
N-Hydroxy-4- ([3]
N-Hydroxy-4- ([3]
N-Hydroxy-4- (2-phenyl-butyrylamino)-benzamide[3]
N-Hydroxy-4- (3-phenyl-propionylamino)-benzamide[3]
N-Hydroxy-4- (4-phenyl-butyrylamino)-benzamide[3]
N-Hydroxy-4- (5-phenyl-pentanoylamino)-benzamide[3]
N-Hydroxy-4- (pentanoylamino-methyl)-benzamide[4]
N-Hydroxy-4- (phenylacetylamino-methyl)-benzamide[4]
N-hydroxy-3- (naphthalen-1-yl)acrylamide[15]
N-hydroxy-4- (naphthalen-1-yl)benzamide[15]
Octanedioic acid hydroxyamide pyridin-2-ylamide[5]
Octanedioic acid hydroxyamide pyridin-4-ylamide[5]
S-2,9-dioxo-9- (phenylamino)nonyl ethanethioate[9]
Suberohydroxamic acid[7]
Thioacetic acid S- (6-phenylcarbamoyl-hexyl) ester[6]
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1Bioorg Med Chem Lett. 2003 Nov 17;13(22):3909-13.Heterocyclic ketones as inhibitors of histone deacetylase. To Reference
Ref 2Bioorg Med Chem Lett. 2008 Mar 15;18(6):1893-7. Epub 2008 Feb 8.New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity. To Reference
Ref 3J Med Chem. 2005 Aug 25;48(17):5530-5.Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. To Reference
Ref 4J Med Chem. 2004 Jan 15;47(2):467-74.Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors. To Reference
Ref 5J Med Chem. 2002 Feb 14;45(4):753-7.Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. To Reference
Ref 6J Med Chem. 2005 Feb 24;48(4):1019-32.Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates. To Reference
Ref 7Nat Chem Biol. 2010 Mar;6(3):238-243. Epub 2010 Feb 7.Chemical phylogenetics of histone deacetylases. To Reference
Ref 8Bioorg Med Chem Lett. 2004 May 17;14(10):2477-81.Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides. To Reference
Ref 9J Med Chem. 2008 Mar 27;51(6):1505-29. Epub 2008 Feb 5.Histone deacetylase inhibitors: from bench to clinic. To Reference
Ref 10J Med Chem. 2006 Jan 26;49(2):800-5.Aromatic sulfide inhibitors of histone deacetylase based on arylsulfinyl-2,4-hexadienoic acid hydroxyamides. To Reference
Ref 11J Med Chem. 2003 Nov 20;46(24):5097-116.Histone deacetylase inhibitors. To Reference
Ref 12J Med Chem. 2009 Jan 22;52(2):456-68.Non-peptide macrocyclic histone deacetylase inhibitors. To Reference
Ref 13Bioorg Med Chem Lett. 2004 May 17;14(10):2617-20.Three new cyclostellettamines, which inhibit histone deacetylase, from a marine sponge of the genus Xestospongia. To Reference
Ref 14Bioorg Med Chem Lett. 2005 Apr 15;15(8):1969-72.Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors. To Reference
Ref 15Bioorg Med Chem Lett. 2007 May 15;17(10):2874-8. Epub 2007 Feb 25.Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. To Reference
Ref 16Bioorg Med Chem Lett. 2009 Apr 15;19(8):2346-9. Epub 2009 Feb 12.N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543